Can the Weight-Loss Drug Semaglutide Reduce Alcohol Cravings

New research suggests that semaglutide – the active ingredient used in the popular weight‑loss drug Wegovy and diabetes treatment Ozempic – may also reduce alcohol cravings. However, a leading alcohol reduction expert has warned against viewing these drugs as miracle fixes. While early studies are promising, the NHS does not approve semaglutide for alcohol reduction, and proven treatments remain the safest, most effective options for long‑term change.

Semaglutide, the active ingredient used in the weight‑loss treatment Wegovy and diabetes drug Ozempic, has taken the world by storm – not only for its dramatic slimming effects but now for a surprising new claim: that it may help people drink less. New research featured in Scientific American this month suggests that medications containing semaglutide, originally licensed for type 2 diabetes and obesity, could reduce cravings for alcohol and even other addictive substances.

While the findings are exciting, however, a leading expert in alcohol reduction is calling for caution, pointing out that semaglutide is not licensed for treating alcohol misuse and that established, evidence‑based treatments for addiction already exist.

‘Semaglutide has changed the landscape when it comes to weight management and treatment for type 2 diabetes, but it’s not a silver bullet for everything,’ says Harvey Bhandal, MD at Sinclair Method UK, specialists in long‑term alcohol reduction treatment. ‘Using these drugs to control drinking habits may sound appealing but, at this stage, it’s purely experimental. There are already safe, approved medications and treatment methods that are clinically proven to manage alcohol dependence.

‘The buzz around semaglutide for alcohol reduction mirrors a recurring theme in our health culture – the search for a quick fix. But when it comes to deep‑rooted habits like drinking, there’s no substitute for a comprehensive, supported plan.

‘Whether it’s a slimming jab or a detox challenge, people love the idea of a shortcut. But real, lasting change depends on addressing harmful behaviour over weeks and months – not just silencing the cravings temporarily.

‘The latest research published in Scientific American notes that individuals taking GLP‑1 drugs such as semaglutides showed a lower risk of substance use, including alcohol. And some scientists are now exploring whether semaglutides could be repurposed to help treat alcohol use disorder.

‘But for now, the NHS only approves semaglutide for type 2 diabetes and weight loss in people with obesity. Any use for alcohol reduction is considered “off‑label,” meaning it falls outside approved medical guidelines.

‘The science is intriguing but it’s far too soon to recommend these injections for anything beyond their licensed use. We need large‑scale, controlled clinical trials before anyone can call this a realistic treatment option for problem drinking.

‘Unlike semaglutide’s potential off‑label use, medications such as naltrexone are already approved by the NHS and other global health authorities for controlling alcohol cravings. Naltrexone works by blocking the release of endorphins triggered by alcohol, breaking the powerful cycle of reward that reinforces drinking.

‘When used within a structured programme, this approach has helped thousands manage their consumption, regaining control and transforming their relationship with alcohol.

‘One of the most recognised and effective treatment options is The Sinclair Method (TSM) – an evidence‑based approach that combines naltrexone with behavioural coaching and medical supervision. Backed by more than 90 clinical trials worldwide, it has demonstrated consistent results, with an 80% success rate in helping people to reduce problematic drinking and rebuild healthier habits.

‘Sinclair Method UK provides prescription‑based treatment programmes designed to help individuals reduce their alcohol consumption safely and sustainably. Each plan includes full medical support from private general practitioners and personalised coaching through online consultations. Consultations are conducted via telephone or video call, and prescriptions for required medications are issued as appropriate. All services are delivered in compliance with strict privacy and confidentiality standards.

‘Founded with direct guidance from Dr Roy Eskapa, a colleague of Dr David Sinclair, whose pioneering research developed the technique, Sinclair Method UK is the only organisation legally licensed to deliver The Sinclair Method in the UK.

For more information, visit: https://www.sinclairmethoduk.com